Aurinia Pharmaceuticals
AUPH
#4832
Rank
ยฃ1.39 B
Marketcap
ยฃ10.62
Share price
-0.82%
Change (1 day)
64.88%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): ยฃ63.06 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.26 Billion. In 2024 the company made an earning of ยฃ8.97 Million, an increase over its 2023 earnings that were of -ยฃ54.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ63.06 M602.6%
2024 ยฃ8.97 M-116.44%
2023 -ยฃ54.58 Million-31.8%
2022 -ยฃ80.03 Million-39.4%
2021 -ยฃ0.14 Billion61.9%
2020 -ยฃ81.58 Million-9.73%
2019 -ยฃ90.37 Million92.65%
2018 -ยฃ46.91 Million36.39%
2017 -ยฃ34.39 Million106.29%
2016 -ยฃ16.68 Million-15.4%
2015 -ยฃ19.71 Million65.84%
2014 -ยฃ11.89 Million129.82%
2013 -ยฃ5.17 Million-26.6%
2012 -ยฃ7.05 Million
2010 -ยฃ3.99 Million-39.22%
2009 -ยฃ6.57 Million-43.78%
2008 -ยฃ11.68 Million-53.19%
2007 -ยฃ24.94 Million42.97%
2006 -ยฃ17.45 Million-23.03%
2005 -ยฃ22.67 Million36.1%
2004 -ยฃ16.66 Million172.57%
2003 -ยฃ6.11 Million484.61%
2002 -ยฃ1.05 Million
2000 -ยฃ4.97 Million453.81%
1999 -ยฃ0.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
ยฃ3.75 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-ยฃ16.17 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-ยฃ4.01 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA